US: Cravath Swaine & Moore, Linklaters, Sullivan & Cromwel and Hengeler Mueller advice on $35 billion Praxair and Linde merger
The $35 billion dollar merger between the industrial gas giants US Praxair and German Linde are being advised by four big international law firms.
Praxair is being represented by Sullivan & Cromwell’s corporate partners Keith Pagnani, Krishna Veeraraghavan and Carsten Berrar. Linde is being represented by Cravath Swaine & Moore’s European M&A head Richard Hall, Aaron Gruber and Len Teti (tax). On the antitrust and regulatory side, Linklaters’ partners Thomas McGrath and Brussels head Bernd Meyringare and corporate partner Maximilian Schiessl from Hengeler Mueller are also representing Linde.
The merger was confirmed on December 20th with Praxair agreeing to purchase Linde for a price tag of $35 billion. This merger will make Praxair the biggest industrial gas giant giving it a new market value of over $65 billion. Linde is known for their technology expertise while Praxair’s reputation for being efficient will be sure to create a successful marriage of the two firms.
Full Content: Leaders League
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas